When we integrated six pan-cancer immune subtypes in our study, we observed that most CCs belonged to the wound healing (26%) or IFN-γ dominant (71%) subtypes, while the other four subtypes only accounted for 3% of CCs. The gene discussed is IFNG; the disease is cancer.